Skip to content

TeleRehabilitation in Hypertension

Isometric Handgrip Exercise: a New Non-pharmacological Tool in the Management of High Blood Pressure?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02705911
Acronym
TRiHYP
Enrollment
60
Registered
2016-03-11
Start date
2015-04-30
Completion date
2016-07-31
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Hypertension, Pre-hypertension

Brief summary

The purpose of this RCT which will be performed in 60 healthy adults is I. To assess the training effects of 8 weeks of isometric handgrip exercise on BP; and to test whether it yields at least similar effects on BP compared to current exercise recommendations. II. To assess whether isometric handgrip training yields larger BP reductions beyond the supervised training period at 6 months of follow-up. III. To determine whether changes in BP following acute exercise and chronic training can be explained by changes in important physiological mechanisms known to mediate or to be associated with BP?

Interventions

Participants have to perform 4 x 2 minute contractions with alternating hands, separated with 1 minute rest period using a ZonaHealth device;

To perform 150 minutes extra/week at moderate aerobic intensity

Sponsors

Research Foundation Flanders
CollaboratorOTHER
KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* not physically active (\< 3 hours of moderate to high levels of PA/week) low cardiovascular risk according to current guidelines (Mancia et al J Hypertens 2013) will be recruited through advertisements. The latter is defined as: * \>115 mmHg \< systolic BP \< 139 mmHg and/or 75 mmHg\< diastolic BP\<90mmHg in the presence of 0 to a maximum of three other cardiovascular risk factors, excluding diabetes Or * 139 mmHg \< systolic BP \< 160 mmHg and/or 90 mmHg\<DBP\< 100 mmHg in the absence of other cardiovascular risk factors

Exclusion criteria

* current smoker * pregnancy * presence of other cardiovascular disease, pulmonary disease or metabolic disease * inability to perform a standard exercise program due to mental/physical disability. * use of antihypertensive drugs

Design outcomes

Primary

MeasureTime frame
change in office blood pressure at 8 weeks of follow-up8 weeks - 6 months

Secondary

MeasureTime frame
change in exercise tolerance (peakVO2 in ml/min/kg) at 8 weeks of follow-up8 weeks - 6 months

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026